Risk of fentanyl overdose among clients of the Sydney Medically Supervised Injecting Centre

International Journal of Drug Policy

Volumn 37, Issue , 2016, Pages 111-114

  Latimer, Julie ^a   Ling, Stephen ^b   Flaherty, Ian ^a   Jauncey, Marianne ^a   Salmon, Allison M ^a  

^a Uniting Medically Supervised Injecting Centre   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Fentanyl; Heroin; Mortality; Overdose; People who inject drugs; Prescription opioids; Safe injecting facilities

Indexed keywords

DIAMORPHINE; FENTANYL; NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG;

ARTICLE; CLINICAL AUDIT; DRUG OVERDOSE; DRUG USE; HUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; ADULT; FEMALE; MALE; NEW SOUTH WALES; PREVENTIVE HEALTH SERVICE; RISK; SUBSTANCE ABUSE;

ADULT; ANALGESICS, OPIOID; CLINICAL AUDIT; DRUG OVERDOSE; FEMALE; FENTANYL; HEROIN; HUMANS; MALE; NEEDLE-EXCHANGE PROGRAMS; NEW SOUTH WALES; PRESCRIPTION DRUGS; RETROSPECTIVE STUDIES; RISK; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84991735521     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2016.08.004     Document Type: Article

References (16)

1. Amlani, A., McKee, G., Khamis, N., Raghukumar, G., Tsang, E., Buxton, J., Why the FUSS (Fentanyl Urine Screen Study)? A cross-sectional survey to characterize an emerging threat to people who use drugs in British Columbia, Canada. Harm Reduction Journal, 12(1), 2015, 54.
2. Anaesthesia UK. Pharmacology of opioids II. http://www.frca.co.uk/article.aspx?articleid=100946.
3. Biancofiore, G., Oxycodone controlled released in cancer pain management. Therapeutics and Clinical Risk Management 2 (2006), 229–234.
4. Canadian Centre on Substance Abuse, Deaths involving fentanyl in Canada, 2009–2014. 2015, CCENDU Bulletin, Ottawa, ON.
5. Centres for Disease Control and Prevention, Nonpharmaceutical fentanyl-related deaths—Multiple states, April 2005–March 2008. MMWR 57:29 (2008), 793–796.
6. Centres for Disease Control and Prevention, Acetyl fentanyl overdose fatalities—Rhode Island, March-May 2013. The Morbidity and Mortality Weekly Report 62:34 (2013), 703–704.
7. Chodoff, P., Domino, E.F., Comparative pharmacology of drugs used in neuroleptanalgesia. Anesthesia and Analgesia 44:5 (1965), 558–563 (comparative study).
8. Compton, W.M., Volkow, N.D., Major increases in opioid analgesic abuse in the United States: Concerns and strategies. Drug and Alcohol Dependence 81:2 (2006), 103–107 (review).
9. Darke, S., Hall, W., Heroin overdose: Research and evidence-based intervention. Journal of Urban Health 80:2 (2003), 189–200.
10. Dietze, P., Jolley, D., Fry, C., Bammer, G., Transient changes in behaviour lead to heroin overdose: Results from a case-crossover study of non-fatal overdose. Addiction 100:5 (2005), 636–642.
11. Drug Enforcement Administration (DEA). (2015). DEA Issues Nationwide Alert on Fentanyl as Threat to Health and Public Safety. Retrieved 09.02.16, from http://www.dea.gov/divisions/hq/2015/hq031815.shtml.
12. Firestone, M., Goldman, B., Fischer, B., Fentanyl use among street drug users in Toronto, Canada: Behavioural dynamics and public health implications. International Journal of Drug Policy 20:1 (2009), 90–92 (Research Support, Non-U.S. Gov't).
13. Kronstrand, R., Druid, H., Holmgren, P., Rajs, J., A cluster of fentanyl-related deaths among drug addicts in Sweden. Forensic Science International 88:3 (1997), 185–193.
14. Reeves, M.D., Ginifer, C.J., Fatal intravenous misuse of transdermal fentanyl. Medical Journal of Australia 177:10 (2002), 552–553.
15. Roxburgh, A., Burns, L., Drummer, O.H., Pilgrim, J., Farrell, M., Degenhardt, L., Trends in fentanyl prescriptions and fentanyl-related mortality in Australia. Drug and Alcohol Review 32:3 (2013), 269–275 (Research Support, Non-U.S. Gov't).
16. Tharp, A.M., Winecker, R.E., Winston, D.C., Fatal intravenous fentanyl abuse: Four cases involving extraction of fentanyl from transdermal patches. The American Journal of Forensic Medicine and Pathology 25:2 (2004), 178–181 (case reports).